Author:
Kang Jukyung,Halseth Troy,Vallejo Daniel,Najafabadi Zeynab Izadi,Sen K. Ilker,Ford Michael,Ruotolo Brandon T.,Schwendeman Anna
Publisher
Springer Science and Business Media LLC
Subject
Biochemistry,Analytical Chemistry
Reference64 articles.
1. U.S. Food and Drug Administration. Biosimilar product information. https://www.fda.gov/drugs/developmentapprovalprocess/howdrugsaredevelopedandapproved/approvalapplications/therapeuticbiologicapplications/biosimilars/ucm580432.htm
2. Vulto AG, Jaquez OA. The process defines the product: what really matters in biosimilar design and production? Rheumatology (Oxford). 2017; Rheumatology (Oxford). 56:iv14–iv29.
3. Pisupati K, Tian Y, Okbazghi S, Benet A, Ackermann R, Ford M, et al. A multidimensional analytical comparison of Remicade and the biosimilar Remsima. Anal Chem. 2017;89:4838–46. https://doi.org/10.1021/acs.analchem.6b04436.
4. Jung SK, Lee KH, Jeon JW, Lee JW, Kwon BO, Kim YJ, et al. Physicochemical characterization of Remsima®. MAbs. 2014;6:1163–77. https://doi.org/10.4161/mabs.32221.
5. Hong J, Lee Y, Lee C, Eo S, Kim S, Lee N, et al. Physicochemical and biological characterization of SB2, a biosimilar of Remicade® (infliximab). MAbs. 2017;9:364–82. https://doi.org/10.1080/19420862.2016.1264550.
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献